Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Nov 20, 2024 | 12.56 | +3.29 |
Oak Valley Bancorp | OVLY | Nov 20, 2024 | 29.08 | -1.16 |
Oak Woods Acquisition | OAKU | Nov 20, 2024 | 11.36 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Nov 20, 2024 | 10.08 | 0.00 |
Oaktree Capital A Pref | OAK-A | Nov 20, 2024 | 23.47 | +0.54 |
Oaktree Capital Group B Pref | OAK-B | Nov 20, 2024 | 22.49 | -0.88 |
Oaktree Specialty | OCSL | Nov 20, 2024 | 15.68 | +0.45 |
Oatly ADR | OTLY | Nov 20, 2024 | 0.67 | +3.84 |
Oblong | OBLG | Nov 20, 2024 | 3.22 | +9.15 |
Occidental Petroleum | OXY | Nov 20, 2024 | 50.91 | +0.81 |
Ocean Biomedical | OCEA | Nov 20, 2024 | 0.69 | -3.99 |
Ocean Power Technologies | OPTT | Nov 20, 2024 | 0.15 | 0.00 |
Oceaneering International | OII | Nov 20, 2024 | 27.97 | +1.82 |
OceanFirst Financial | OCFC | Nov 20, 2024 | 19.98 | -0.70 |
OceanFirst Pref | OCFCP | Nov 20, 2024 | 25.20 | -0.55 |
OceanPal | OP | Nov 20, 2024 | 1.42 | -0.11 |
Ocugen | OCGN | Nov 20, 2024 | 0.92 | +5.14 |
Ocular Therapeutix | OCUL | Nov 20, 2024 | 8.78 | -1.57 |
Oculis | OCS | Nov 20, 2024 | 14.91 | -0.73 |
Ocuphire Pharma | OCUP | Nov 20, 2024 | 1.17 | 0.00 |
Oddity Tech | ODD | Nov 20, 2024 | 40.31 | -0.47 |
Odyssey Marine Exploration | OMEX | Nov 20, 2024 | 0.40 | -0.77 |
Offerpad Solutions A | OPAD | Nov 20, 2024 | 3.58 | -2.72 |
Office Properties | OPI | Nov 20, 2024 | 1.12 | -3.45 |
OFG Bancorp | OFG | Nov 20, 2024 | 43.44 | 0.00 |
OFS Capital | OFS | Nov 20, 2024 | 8.08 | +0.50 |
OFS Credit | OCCI | Nov 20, 2024 | 7.10 | -0.14 |
OFS Credit C Pref | OCCIO | Nov 20, 2024 | 24.70 | 0.00 |
OFS Credit Company Pref F | OCCIM | Nov 20, 2024 | 24.93 | 0.00 |
OFS Credit E Pref | OCCIN | Nov 20, 2024 | 23.96 | +0.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.